Author Correction: Heritable polygenic editing: the next frontier in genomic medicine?
Peter M. Visscher, Christopher Gyngell, Loic Yengo, Julian Savulescu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCRISPR and Genetic Engineering
Correction to: Nature 10.1038/s41586-024-08300-4 Published online 8 January 2025
In the version of the article initially published, two simulation studies that modelled the effect of germline gene editing on human disease were omitted and have now been added as refs. 20 and 21: Oliynyk, R. T. Quantifying the potential for future gene therapy to lower lifetime risk of polygenic late-onset diseases. Int. J. Mol. Sci. 10.3390/ijms20133352 (2019) and Oliynyk, R. T. Future preventive gene therapy of polygenic diseases from a population genetics perspective. Int. J. Mol. Sci. 10.3390/ijms20205013 (2019). The authors regret this omission and have added a sentence to the main text and a paragraph in the revised Supplementary Note 1.